Oxybutynin Chloride is Used for managing incontinence, hormone replacement therapy, treating involuntary incontinence, managing overactive bladder, and increasing compliance in patients. It was first introduced by Ortho Mcneil Janssen Pharmaceuticals Inc in its drug Ditropan on Approved Prior to Jan 1, 1982. Other drugs containing Oxybutynin Chloride are Ditropan Xl, Gelnique. 32 different companies have introduced drugs containing Oxybutynin Chloride.

Oxybutynin Chloride Patents

Given below is the list of patents protecting Oxybutynin Chloride, along with the drug name that holds that patent and the company name owning that drug.

Download patent list as spreadsheet

Get the complete list right in your inbox!

Drug Used in	Drug Patent Number	Drug Patent Title	Drug Patent Expiry	Drug Owner
Gelnique	US8920392	Method for treating overactive bladders and a device for storage and administration of topical oxybutynin compositions	Mar 26, 2031	Abbvie
Gelnique	US10449173	Method for treating overactive bladders and a device for storage and administration of topical oxybutynin compositions	Nov 06, 2029	Abbvie
Gelnique	US9259388	Method for treating overactive bladders and a device for storage and administration of topical oxybutynin compositions	Nov 06, 2029	Abbvie
Gelnique	US10272061	Compositions and methods for unoccluded transdermal oxybutynin therapy	Apr 26, 2020 (Expired)	Abbvie
Gelnique	US7029694	Compositions and methods for transdermal oxybutynin therapy	Apr 26, 2020 (Expired)	Abbvie
Gelnique	US7179483	Compositions and methods for transdermal oxybutynin therapy	Apr 26, 2020 (Expired)	Abbvie
Gelnique	US8241662	Unoccluded topical oxybutynin gel composition and methods for transdermal oxybutynin therapy	Apr 26, 2020 (Expired)	Abbvie
Ditropan Xl	US5674895 (Pediatric)	Dosage form comprising oxybutynin	Nov 22, 2015 (Expired)	Janssen Pharms
Ditropan Xl	US5840754 (Pediatric)	Dosage form comprising oxybutynin	Nov 22, 2015 (Expired)	Janssen Pharms
Ditropan Xl	US5912268 (Pediatric)	Dosage form and method for treating incontinence	Nov 22, 2015 (Expired)	Janssen Pharms
Ditropan Xl	US6262115 (Pediatric)	Method for the management of incontinence	Nov 22, 2015 (Expired)	Janssen Pharms
Ditropan Xl	US5674895	Dosage form comprising oxybutynin	May 22, 2015 (Expired)	Janssen Pharms
Ditropan Xl	US5840754	Dosage form comprising oxybutynin	May 22, 2015 (Expired)	Janssen Pharms
Ditropan Xl	US5912268	Dosage form and method for treating incontinence	May 22, 2015 (Expired)	Janssen Pharms
Ditropan Xl	US6262115	Method for the management of incontinence	May 22, 2015 (Expired)	Janssen Pharms

Add above patents to watchlist

Oxybutynin Chloride's Family Patents

Full family tree

Oxybutynin Chloride Generic API Manufacturers

Several generic applications have been filed for Oxybutynin Chloride. The first generic version for Oxybutynin Chloride was by Usl Pharma Inc and was approved on Mar 10, 1988. And the latest generic version is by Rising Pharma Holdings Inc and was approved on Feb 7, 2023.

Given below is the list of companies who have filed for Oxybutynin Chloride generic, along with the locations of their manufacturing plants worldwide.